SynBioVen (investor - Others)
See something wrong or missing? Let us know
Offices:London
SynBioVen is an investment company backed by British politician David Lindsay Willetts and Richard Ian Kitney, a professor at London's Imperial College.
Average round investment:7.34M USD
Average number per year:2.2
Distribution:
2026 (1)2025 (2)2024 (1)2023 (3)2022 (4)
Mostly invests in:
United Kingdom (10)
Biotech (10)
United Kingdom (10)
Biotech (10)
See the entire list
Showing 3 of 11 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
SynBioVen mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to SynBioVen
| Name | Criteria | |
|---|---|---|
![]() |
Felipe Navio
100%
|
|
![]() |
Bleu Capital
100%
|
|
![]() |
V3 Ventures
100%
|
|
![]() |
Angelor
100%
|
|
![]() |
Celsius Industries
100%
|
|
![]() |
Ankaa Ventures
100%
|
|
![]() |
SixThirty Ventures
100%
|
|
![]() |
Nathalie Balla
100%
|
|
![]() |
Dan Cobley
100%
|
|
![]() |
A Plus Finance
100%
|
|



Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal